These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 26718724)

  • 21. N-Terminal Domains of Cardiac Myosin Binding Protein C Cooperatively Activate the Thin Filament.
    Risi C; Belknap B; Forgacs-Lonart E; Harris SP; Schröder GF; White HD; Galkin VE
    Structure; 2018 Dec; 26(12):1604-1611.e4. PubMed ID: 30270174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-stimulated contraction: A predictor of thin-filament activation in cardiac disease.
    Sequeira V; Najafi A; Wijnker PJ; Dos Remedios CG; Michels M; Kuster DW; van der Velden J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E7003-12. PubMed ID: 26621701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
    Robinson P; Griffiths PJ; Watkins H; Redwood CS
    Circ Res; 2007 Dec; 101(12):1266-73. PubMed ID: 17932326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.
    McNamara JW; Li A; Smith NJ; Lal S; Graham RM; Kooiker KB; van Dijk SJ; Remedios CGD; Harris SP; Cooke R
    J Mol Cell Cardiol; 2016 May; 94():65-71. PubMed ID: 27021517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
    Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
    Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
    Borovikov IuS; Karpicheva OE; Rysev NA; Redwood CS
    Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):73-80. PubMed ID: 23659058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immediate effect of HCM causing actin mutants E99K and A230V on actin-Tm-myosin interaction in thin-filament reconstituted myocardium.
    Bai F; Caster HM; Dawson JF; Kawai M
    J Mol Cell Cardiol; 2015 Feb; 79():123-32. PubMed ID: 25451174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin.
    Bezold KL; Shaffer JF; Khosa JK; Hoye ER; Harris SP
    J Biol Chem; 2013 Jul; 288(30):21496-505. PubMed ID: 23782699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability.
    Smelter DF; de Lange WJ; Cai W; Ge Y; Ralphe JC
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1179-H1191. PubMed ID: 29451820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments.
    Cimiotti D; Fujita-Becker S; Möhner D; Smolina N; Budde H; Wies A; Morgenstern L; Gudkova A; Sejersen T; Sjöberg G; Mügge A; Nowaczyk MM; Reusch P; Pfitzer G; Stehle R; Schröder RR; Mannherz HG; Kostareva A; Jaquet K
    PLoS One; 2020; 15(3):e0229227. PubMed ID: 32182250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple forms of cardiac myosin-binding protein C exist and can regulate thick filament stability.
    Kulikovskaya I; McClellan GB; Levine R; Winegrad S
    J Gen Physiol; 2007 May; 129(5):419-28. PubMed ID: 17470661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
    Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
    Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
    Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
    J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cardiac myosin-binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner.
    Bunch TA; Kanassatega RS; Lepak VC; Colson BA
    J Biol Chem; 2019 Nov; 294(44):16228-16240. PubMed ID: 31519753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy.
    Li XE; Suphamungmee W; Janco M; Geeves MA; Marston SB; Fischer S; Lehman W
    Biochem Biophys Res Commun; 2012 Aug; 424(3):493-6. PubMed ID: 22789852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryo-EM structures of the actin:tropomyosin filament reveal the mechanism for the transition from C- to M-state.
    Sousa DR; Stagg SM; Stroupe ME
    J Mol Biol; 2013 Nov; 425(22):4544-55. PubMed ID: 24021812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural basis for Ca2+-regulated muscle relaxation at interaction sites of troponin with actin and tropomyosin.
    Murakami K; Yumoto F; Ohki SY; Yasunaga T; Tanokura M; Wakabayashi T
    J Mol Biol; 2005 Sep; 352(1):178-201. PubMed ID: 16061251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of thin filament activation of myosin ATP hydrolysis by N-terminal domains of cardiac myosin binding protein-C.
    Belknap B; Harris SP; White HD
    Biochemistry; 2014 Oct; 53(42):6717-24. PubMed ID: 25265574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD; Lynch TL; Barefield DY; Sivaguru M; Kuffel G; Zilliox MJ; Lee KH; Craig R; Namakkal-Soorappan R; Sadayappan S
    Cardiovasc Res; 2019 Dec; 115(14):1986-1997. PubMed ID: 31050699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.